These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 17917564

  • 1. The interaction between the internal clock and antidepressant efficacy.
    Racagni G, Riva MA, Popoli M.
    Int Clin Psychopharmacol; 2007 Oct; 22 Suppl 2():S9-S14. PubMed ID: 17917564
    [Abstract] [Full Text] [Related]

  • 2. Pharmacology of a new antidepressant: benefit of the implication of the melatonergic system.
    Fuchs E, Simon M, Schmelting B.
    Int Clin Psychopharmacol; 2006 Feb; 21 Suppl 1():S17-20. PubMed ID: 16436935
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Agomelatine beyond borders: current evidences of its efficacy in disorders other than major depression.
    De Berardis D, Fornaro M, Serroni N, Campanella D, Rapini G, Olivieri L, Srinivasan V, Iasevoli F, Tomasetti C, De Bartolomeis A, Valchera A, Perna G, Mazza M, Di Nicola M, Martinotti G, Di Giannantonio M.
    Int J Mol Sci; 2015 Jan 05; 16(1):1111-30. PubMed ID: 25569089
    [Abstract] [Full Text] [Related]

  • 5. Evidence of agomelatine's antidepressant efficacy: the key points.
    Eser D, Baghai TC, Möller HJ.
    Int Clin Psychopharmacol; 2007 Oct 05; 22 Suppl 2():S15-9. PubMed ID: 17917562
    [Abstract] [Full Text] [Related]

  • 6. Agomelatine in depressive disorders: its novel mechanisms of action.
    Srinivasan V, Zakaria R, Othman Z, Lauterbach EC, Acuña-Castroviejo D.
    J Neuropsychiatry Clin Neurosci; 2012 Oct 05; 24(3):290-308. PubMed ID: 23037643
    [Abstract] [Full Text] [Related]

  • 7. Synergistic mechanisms involved in the antidepressant effects of agomelatine.
    Tardito D, Molteni R, Popoli M, Racagni G.
    Eur Neuropsychopharmacol; 2012 Oct 05; 22 Suppl 3():S482-6. PubMed ID: 22867907
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Beyond the monoaminergic hypothesis: agomelatine, a new antidepressant with an innovative mechanism of action.
    Kasper S, Hamon M.
    World J Biol Psychiatry; 2009 Oct 05; 10(2):117-26. PubMed ID: 19255935
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Agomelatine: the first "melatoninergic" antidepressant].
    Bánki MC.
    Neuropsychopharmacol Hung; 2006 Oct 05; 8(3):105-12. PubMed ID: 17211046
    [Abstract] [Full Text] [Related]

  • 12. Circadian rhythms, melatonin and depression.
    Quera Salva MA, Hartley S, Barbot F, Alvarez JC, Lofaso F, Guilleminault C.
    Curr Pharm Des; 2011 Oct 05; 17(15):1459-70. PubMed ID: 21476953
    [Abstract] [Full Text] [Related]

  • 13. Addressing circadian rhythm disturbances in depressed patients.
    Lam RW.
    J Psychopharmacol; 2008 Sep 05; 22(7 Suppl):13-8. PubMed ID: 18753278
    [Abstract] [Full Text] [Related]

  • 14. Mode of action of agomelatine: synergy between melatonergic and 5-HT2C receptors.
    Racagni G, Riva MA, Molteni R, Musazzi L, Calabrese F, Popoli M, Tardito D.
    World J Biol Psychiatry; 2011 Dec 05; 12(8):574-87. PubMed ID: 21999473
    [Abstract] [Full Text] [Related]

  • 15. The mechanism, efficacy, and tolerability profile of agomelatine.
    MacIsaac SE, Carvalho AF, Cha DS, Mansur RB, McIntyre RS.
    Expert Opin Pharmacother; 2014 Feb 05; 15(2):259-74. PubMed ID: 24328686
    [Abstract] [Full Text] [Related]

  • 16. Agomelatine, a melatonin agonist with antidepressant properties.
    Dubovsky SL, Warren C.
    Expert Opin Investig Drugs; 2009 Oct 05; 18(10):1533-40. PubMed ID: 19758108
    [Abstract] [Full Text] [Related]

  • 17. Melatonin receptor agonist agomelatine: a new drug for treating unipolar depression.
    Bourin M, Prica C.
    Curr Pharm Des; 2009 Oct 05; 15(14):1675-82. PubMed ID: 19442180
    [Abstract] [Full Text] [Related]

  • 18. Melatonergic drugs in clinical practice.
    Hardeland R, Poeggeler B, Srinivasan V, Trakht I, Pandi-Perumal SR, Cardinali DP.
    Arzneimittelforschung; 2008 Oct 05; 58(1):1-10. PubMed ID: 18368944
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Activation of Melatonin Receptors Reduces Relapse-Like Alcohol Consumption.
    Vengeliene V, Noori HR, Spanagel R.
    Neuropsychopharmacology; 2015 Dec 05; 40(13):2897-906. PubMed ID: 25994077
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.